Neoadjuvant chemoradiotherapy followed by esophagectomy for initially resectable squamous cell carcinoma of the esophagus with multiple lymph node metastasis

Diseases of the Esophagus

Volumn 18, Issue 6, 2005, Pages 388-397

  Nabeya, Yoshihiro ^a   Ochiai, T ^a   Matsubara, H ^a   Okazumi, S ^a   Shiratori, T ^a   Shuto, K ^a   Aoki, T ^a   Miyazaki, S ^a   Gunji, Y ^a   Uno, T ^a   Ito, H ^a   Shimada, H ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Esophageal squamous cell carcinoma; Esophagectomy; Lymph node metastasis; Neoadjuvant chemoradiotherapy; Three field lymphadenectomy

Indexed keywords

CISPLATIN; FLUOROURACIL; GRANULOCYTE COLONY STIMULATING FACTOR; METHYLPREDNISOLONE; NEDAPLATIN; ANTINEOPLASTIC AGENT; CF REGIMEN;

ADULT; AGED; ARTICLE; BOLUS INJECTION; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS RESECTION; FEMALE; HUMAN; KAPLAN MEIER METHOD; LEUKOPENIA; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; PERIOPERATIVE PERIOD; POSTOPERATIVE CARE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SURVIVAL RATE; ADJUVANT THERAPY; COMPARATIVE STUDY; ESOPHAGUS TUMOR; LYMPH NODE; METASTASIS; MIDDLE AGED; MORTALITY; PATHOLOGY; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FLUOROURACIL; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; PROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 33644820237     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2005.00521.x     Document Type: Article

References (31)

1. Harrison L E. Is esophageal cancer a surgical disease? J Surg Oncol 2000; 75: 227-31.
2. Ando N, Ozawa S, Kitagawa Y, Shinozawa Y, Kitajima M. Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years. Ann Surg 2000; 232: 225-32.
3. Isono K. Surgical treatment of esophageal cancer: Present aspects and new trends. In: Pinotti H W, Cecconello I, Felix V N, deOliveira M A, (eds). Recent Advances in Diseases of the Esophagus. Bologna: Monduzzi Editore S p A 2001, 111-6.
4. Ando N, Iizuka T, Ide H et al. A randomized trial of surgery alone vs surgery plus postoperative chemotherapy with cisplatin and 5-Fluorouracil for localized squamous carcinoma of the thoracic esophagus: The Japan Clinical Oncology Group Study (JCOG 9204). Proc Am Soc Clin Oncol 1999; 18: 269a.
5. Jones D R, Detterbeck F C, Egan T M, Parker L A Jr, Bernard S A, Tepper J E. Induction chemoradiotherapy followed by esophagectomy in patients with carcinoma of the esophagus. Ann Thorac Surg 1997; 64: 185-91.
6. Slater M S, Holland J, Faigel D O, Sheppard B C, Deveney C W. Does neoadjuvant chemoradiation downstage esophageal carcinoma? Am J Surg 2001; 181: 440-4.
7. Hennequin C, Gayet B, Sauvanet A et al. Impact on survival of surgery after concomitant chemoradiotherapy for locally advanced cancers of the esophagus. Int J Radiat Oncol Biol Phys 2001; 49: 657-64.
8. Averbach A, Akbarov A, Sidel T et al. Results of curative therapy for esophageal cancer in a community training hospital. Int Surg 2002; 87: 31-7.
9. Lee J L, Kim S B, Jung H Y et al. Efficacy of neoadjuvant chemoradiotherapy in resectable esophageal squamous cell carcinoma. Acta Oncol 2003; 42: 207-11.
10. Le Prise E, Etienne P L, Meunier B et al. A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus. Cancer 1994; 73: 1779-84.
11. Walsh T N, Noonan N, Hollywood D, Kelly A, Keeling N, Hennessy T P. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Eng J Med 1996; 335: 462-7.
12. Bosset J F, Gignoux M, Triboulet J P et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 1997; 337: 161-7.
13. Urba S G, Orringer M B, Turrisi A, Iannettoni M, Forastiere A, Strawderman M. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 2001; 19: 305-13.
14. Sobin L H, Wittekind C. International Union Against Cancer: TNM Classification of Malignant Tumours, 6th edn. New York: Wiley-Liss, Inc. 2002.
15. Noguchi T, Moriyama H, Wada S et al. Resection surgery with neoadjuvant chemoradiotherapy improves outcomes of patients with T4 esophageal carcinoma. Dis Esophagus 2003; 16: 94-8.
16. Isono K, Sato H, Nakayama K. Results of a nationwide study on the three-field lymph node dissection of esophageal cancer. Oncology 1991; 48: 411-20.
17. Fujita H, Kakegawa T, Yamana H et al. Mortality and morbidity rates, postoperative course, quality of life, and prognosis after extended radical lymphadenectomy for esophageal cancer. Comparison of three-field lymphadenectomy with two-field lymphadenectomy. Ann Surg 1995; 222: 654-62.
18. Altorki N K, Kent M, Ferrara C, Port J. Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus. Ann Surg 2002; 236: 177-83.
19. El Nakadi I, Van Laethem J L, Houben J J et al. Squamous cell carcinoma of the esophagus: Multimodal therapy in locally advanced disease. World J Surg 2002; 26: 72-8.
20. Guillem P, Fabre S, Mariette C, Triboulet J P. Surgery after induction chemoradiotherapy for oesophageal cancer. Eur J Surg Oncol 2003; 29: 158-65.
21. Ohtsu A, Boku N, Muro K et al. Definitive chemoradiotherapy for T4 and/ or M1 lymph node squamous cell carcinoma of the esophagus. J Clin Oncol 1999; 17: 2915-21.
22. Geh J I. The use of chemoradiotherapy in oesophageal cancer. Eur J Cancer 2002; 38: 300-13.
23. Kawahara K, Maekawa T, Okabayashi K et al. The number of lymph node metastases influences survival in esophageal cancer. J Surg Oncol 1998; 67: 160-3.
24. Arima M, Koide Y, Okazumi S et al. Indications and limitations of 3-field lymph node dissection for thoracic esophageal carcinoma (in Japanese with English abstract). Jpn J Gastroenterol Surg 1999; 32: 2484-8.
25. Shimada H, Ochiai T, Okazumi S et al. Clinical benefits of steroid therapy on surgical stress in patients with esophageal cancer. Surgery 2000; 128: 791-8.
26. Okazumi S, Ochiai T, Shimada H et al. Development of less invasive surgical procedures for thoracic esophageal cancer. Dis Esophagus 2004; 17: 159-63.
27. Toyoizumi S, Usui S, Sakamoto A et al. Study of risk factors for postoperative pulmonary complication following esophageal cancer surgery: Multivariate statistical analysis (in Japanese with English abstract). Jap J Thorac Cardiovasc Surg 1990; 38: 215-21.
28. Kunisaki C, Takahashi M, Moriwaki Y et al. Risk factors of postoperative respiratory complications after esophagectomy from the immunonutritional aspects (in Japanese with English abstract). Jpn J Gastroenterol Surg 1999; 32: 2208-13.
29. Cooper J S, Guo M D, Herskovic A et al. Chemoradiotherapy of locally advanced esophageal cancer: Long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group JAMA 1999; 281: 1623-7.
30. Chan A, Wong A. Is combined chemotherapy and radiation therapy equally effective as surgical resection in localized esophageal carcinoma? Int J Radiat Oncol Biol Phys 1999; 45: 265-70.
31. Shimada H, Hoshino T, Okazumi S et al. Expression of angiogenic factors predicts response to chemoradiotherapy and prognosis of oesophageal squamous cell carcinoma. Br J Cancer 2002; 86: 552-7.